Literature DB >> 35118460

Congenital Adrenal Hyperplasia Due to 17-α-hydroxylase Deficiency: A Case Report.

Lucas Ribeiro Dos Santos1, Erico Paulo Heilbrun1, Charles Simões Félix1, Márcio Luis Duarte2.   

Abstract

Congenital adrenal hyperplasia, an innate error in adrenal steroid biosynthesis, triggers a wide range of consequences based on the level of enzyme blockade. Due to the various forms of enzyme deficiency and degree of penetration, the clinical features are very variable. In this case report, we present a form of congenital adrenal hyperplasia due to an enzymatic defect of CYP17A1, with a late diagnosis. The recognition of this pathology should occur as early as possible to avoid sequelae, both metabolic and psychological. © Touch Medical Media 2021.

Entities:  

Keywords:  46; Adrenal insufficiency; XY; adrenal hyperplasia; congenital; disorder of sex development

Year:  2021        PMID: 35118460      PMCID: PMC8676104          DOI: 10.17925/EE.2021.17.2.138

Source DB:  PubMed          Journal:  touchREV Endocrinol        ISSN: 2752-5457


  10 in total

1.  Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency.

Authors:  Marivânia Costa-Santos; Claudio E Kater; Richard J Auchus
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

Review 2.  Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development.

Authors:  Ayhan Abacı; Gönül Çatlı; Merih Berberoğlu
Journal:  J Pediatr Endocrinol Metab       Date:  2015-09       Impact factor: 1.634

Review 3.  Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic.

Authors:  Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2016-02-06       Impact factor: 4.292

4.  Primary amenorrhoea with hypertension: undiagnosed 17-α-hydroxylase deficiency.

Authors:  Fiona L Britten; Kimberly B Ulett; Emma L Duncan; Donald A Perry-Keene
Journal:  Med J Aust       Date:  2013-10-21       Impact factor: 7.738

5.  Genotyping of five chinese patients with 17alpha-hydroxylase deficiency diagnosed through high-performance liquid chromatography serum adrenal profile: identification of two novel CYP17 mutations.

Authors:  Ji-Qing Wei; Ji-Lu Wei; Wei-Chun Li; Yun-Sheng Bi; Feng-Cai Wei
Journal:  J Clin Endocrinol Metab       Date:  2006-07-05       Impact factor: 5.958

Review 6.  Fertility in patients with genetic deficiencies of cytochrome P450c17 (CYP17A1): combined 17-hydroxylase/17,20-lyase deficiency and isolated 17,20-lyase deficiency.

Authors:  Courtney A Marsh; Richard J Auchus
Journal:  Fertil Steril       Date:  2014-02       Impact factor: 7.329

7.  Steroid 17alpha-hydroxylase deficiency: functional characterization of four mutations (A174E, V178D, R440C, L465P) in the CYP17A1 gene.

Authors:  Vivek Dhir; Nicole Reisch; Caroline M Bleicken; Jan Lebl; Clemens Kamrath; Hans-Peter Schwarz; Joachim Grötzinger; Wolfgang G Sippell; Felix G Riepe; Wiebke Arlt; Nils Krone
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

8.  Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial.

Authors:  Eleanor M Gurnell; Penelope J Hunt; Suzanne E Curran; Catherine L Conway; Eleanor M Pullenayegum; Felicia A Huppert; Juliet E Compston; Joseph Herbert; V Krishna K Chatterjee
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

9.  Deficiency of 17,20-lyase causing giant ovarian cysts in a girl and a female phenotype in her 46,XY sister: case report.

Authors:  Marianne J ten Kate-Booij; Christa Cobbaert; Jan W Koper; Frank H de Jong
Journal:  Hum Reprod       Date:  2004-02       Impact factor: 6.918

10.  Dexamethasone-suppressible hypercorticosteronism in two 46,XX subjects with ambiguous genitalia and ovarian cysts. Partial defect of 17 alpha-hydroxylase or 17-20-desmolase.

Authors:  M Roger; R E Merceron; F Girard; P Canlorbe; L Dehennin; P Konopka; J Seneze; J E Toublanc
Journal:  Horm Res       Date:  1982
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.